EP3570940

PRIDOPIDINE FOR USE IN THE TREATMENT OF FRAGILE X SYNDROME

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    18.1.2018
  • EP published:
    13.12.2023
  • EP application number:
    18741607.8
  • Max expiry date:
    17.1.2038
  • Title in English:
    PRIDOPIDINE FOR USE IN THE TREATMENT OF FRAGILE X SYNDROME
  • Language of the patent:
    English

Timeline

Today
18.1.2018EP application
13.12.2023EP Publication

Owner

  • Name:
    Prilenia Neurotherapeutics Ltd.
  • Address:
    10 HaMenofim Street, 4672561 Herzliya, IL
  • Name:
    National University of Singapore
  • Address:
    21 Lower Kent Ridge Road, Singapore 119077, SG
  • Name:
    Agency for Science, Technology and Research
  • Address:
    1 Fusionopolis Way 20-10 Connexis North, Singapore 138632, SG

Inventor

  • Name:
    HAYDEN, Michael
  • Address:
    49131 Petach-tikva, IL
  • Name:
    POULADI, Mahmoud, Abdulhossein
  • Address:
    Singapore 129789, SG

Priority

  • Number:
    201762448595 P
  • Date:
    20.1.2017
  • Country:
    US

Classification

  • Categories:
    A61K 31/451, A61K 45/06, A61P 25/28

Upload documents